Open

Request Ticket // Limit: 1 // Tickets Available: 1 

Application Limits: 
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Purpose: 
The purpose of this program is to increase awareness and equitable access to HRSA’s Living Organ Donation Reimbursement Program (LODRP), particularly among medically underserved communities, through targeted outreach and education initiatives.

Request Ticket // Limit: 1 // Tickets Available: 1

Application Limits:
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Purpose:
The purpose of this program is to reduce financial disincentives to living organ donation by providing means-tested reimbursement of lost wages, transportation, meals, and dependent care (child care and elder care) expenses and other qualified expenses to living organ donors.

Request Ticket // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation Postdoctoral Fellowship in Drug Discovery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug discovery research.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Discovery Postdoctoral Fellowship webpage.

Request Ticket // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation Postdoctoral Fellowship in Drug Delivery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Postdoctoral Fellowship webpage.

Request Ticket // Limit: 1 predoctoral applicant per lab

M.P. Resmi (Ganesh Lab, Department of Molecular Medicine) 

The PhRMA Foundation Predoctoral Fellowship in Drug Delivery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Predoctoral Fellows webpage.

Request Ticket // Limit: 1 predoctoral applicant per lab

The PhRMA Foundation’s Predoctoral Fellowship in Translational Medicine supports promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in translational medicine.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Translational Medicine Predoctoral Fellowship webpage.

Request Ticket // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation’s Postdoctoral Fellowship in Translational Medicine supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in translational medicine.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Postdoctoral Fellowships - Translational Medicine webpage.

Request Ticket // Limit: 1 predoctoral applicant per lab

The PhRMA Foundation Predoctoral Fellowship in Drug Discovery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug discovery research.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Discovery Predoctoral Fellowship webpage. 

Request Ticket // Limit: 1 // Tickets Avaialbe: 1

The University of Arizona Cancer Center (UACC) can nominate one individual for the 2026 Pew-Stewart Scholars for Cancer Research program. For more information please contact: UACC-PreAward.

In line with The Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research at NCI-designated cancer centers, or cancer-focused institutions. The Pew-Stewart Scholars Program for Cancer Research is distinct from the Pew Scholars Program, and it follows a different, but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer.

In early April 2025, a letter of invitation and application instructions will be sent to the leaders of the cancer research institutions selected to submit a nominee for the 2026 class. Centers are expected to complete a limited submission competition in order to identify and select one nominee. For guidance on this process, please contact Pew-Stewart@pewtrusts.org.

• Center administration should distribute this invitation and award eligibility details to all investigators via an email announcement or website posting.
• Interested applicants should submit pre-proposal material to an internal selection committee for consideration.
• To nominate a candidate, a member of the internal selection committee must complete an online survey from the Pew program office describing the selection process used by the institution and submit the name and contact information of the chosen applicant by May 14, 2025.
• Nominations of applicants to the program will not be considered after May 14, 2025.
• The Pew program office will email grant application portal login information and a detailed application guide directly to all nominated applicants by June 11, 2025. The online application website will open on June 11, 2025.
• For research administrators assisting an applicant, please send an email with your grant applicant cc’ed to Pew-Stewart@pewtrusts.org after June 11, 2025, to receive access to the portal. No requests will be accepted prior to this date.
• The application submission deadline is Aug. 27, 2025.
• Every application will be reviewed by the program's National Advisory Committee. The committee will make recommendations to the board of directors of The Pew Charitable Trusts in April 2026. Candidates will be notified in April if they have been recommended to the Stewart and Pew boards.
• A public announcement of the award will be made in June. Grant agreements will be issued to the grant hosting institution of each scholar in August of the award year.

Request Ticket // Limit: 2 // Tickets Available: 2

Number of Applications
The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

• A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
• A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
• An application that has substantial overlap with another application pending appeal of initial peer review (see 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Two applications per institution (with a Unique Entity Identifier ) and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission.

Applications that are not considered to be within the NIGMS mission will not be reviewed. Eligibility and appropriateness to the NIGMS mission will be evaluated again after review and prior to funding. Applications outside the NIGMS mission will not be funded. Given that only two applications are permitted per institution per review round, it is important to contact NIGMS staff before committing to any particular team and its topic area.

Purpose: 
This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.